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Abstract We reported earlier the presence of a 40 kDa plasma 
membrane fatty acid-binding protein (FABP,,) in human pla- 
centa. This protein is thought to be involved in the sequestration 
of unesteril?ed free fatty acids bound to albumin from the mater- 
nal plasma for delivery to the fetus. However, its location in 
human placental syncytiotrophoblasts is not known. These cells 
are bipolar; one side facing maternal circulation (microvigous 
membranes), and the other side facing fetal circulation (basal 
membranes). Therefore, it is important to resolve the location of 
this protein in trophoblast membranes in order to understand 
fatty acid transport and metabolism in human placenta. Isolated 
plasma membranes vesicles were prepared respectively from the 
maternal facing microvillous and fetal facing surface of the 
human full-term placental syncytiotrophoblast. Using these mem- 
brane preparations, fatty acid binding activity, the poly- 
acrylamide gel electrophoresis radiobinding assay for FABP,,, 
and Western blot analysis of FABP,, were carried out to deter- 
mine the location of this protein in these membranes. Based on 
the above studies we conclude that the FABP,, is located exclu- 
sively in the microvillous membranes. Since FABP,, may be 
responsible for FFA uptake, its location in the microvillous mem- 
branes favours the unidirectional flow of maternal FFA to the 
fetus. 
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I. Introduction 
The developing fetus and the placenta require essential fatty 
;,cids (EFA) and their desaturated and elongated derivatives 
I LCPUFA) for the formation of structural components of cell 
J ‘membranes, and for participation in intracellular signalling [l- 
1. Unesterified free fatty acids (FFA) in the maternal circula- 
I ton are the major source of fatty acids across the placenta, as 
I riglycerides are not transported intact [6]. The placental lipo- 
llrotein lipase [LPL] present in microvillous membranes is 
I hought to be mainly responsible for hydrolysis to facilitate 
~llacental uptake of FFA from circulating triglycerides [1,5,7]. 
in different tissues, particularly in the heart, FFA uptake has 
lIeen shown to be mediated via the FABP,, [8-l 11. We recently 
lnrrified and characterized a FABP,, both in human [12] and 
heep placental membranes [13]. We suggested that this protein 
I nay play an important role in the preferential accumulation of 
“:FAILCPUFA in the fetal circulation [.5,12]. However, the 
i xact location of this protein in placental membranes has to be 
~letermined in order to understand its role in fatty acid trans- 
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port and metabolism in the feto-placental unit. Clarification 
will involve a direct functional comparison of the fatty acid 
binding sites in the two membranes. The human placental 
syncytiotrophoblast is a continuous epithelial barrier separat- 
ing maternal blood from the fetal placental villous vasculature. 
The apical surface of the syncytium is in direct contact with 
maternal blood in the placental intervillous space. All sub- 
stances crossing the placenta in either direction must therefore 
diffuse or be transported across both this epithelial layer and 
the endothelial lining of the fetal vessels. In our previous studies 
crude plasma membranes were used to identify a FABP,, in 
human placenta [12]. In the present paper, we investigated the 
presence of FABP,, in the purified maternal or fetal facing 
plasma membranes from the human placental syncytiotro- 
phoblast. The studies outlined in this paper provide evidence 
for the presence of FABP,, in microvillous membranes of 
human syncytiotrophoblast. 
2. Materials and methods 
2. I Materials and reagents 
[ 1 -?Z]Oleic acid (53 mCi/mmol), [ l-‘4C]linoleic acid (58 mCi/mmol) 
were obtained from Amersham, UK. [‘HlDihydroalprenolol (55 Ci/ 
mmol) was obtained from New England Nuclear, UK. Bovine serum 
albumin (fat free), Triton X-100, and rn-propanolol were obtained 
from Sigma, Poole, UK. All reagents used were of analytical grade 
quality. 
2.2. Human placental membrane preparations 
Human placentas were obtained within 1 h of delivery from Aber- 
deen Maternity Hospital, Aberdeen. Highly purified microvillous and 
basal membranes were prepared from the placenta following a method 
described earlier [14]. After removing chorionic and basal plates, villous 
tissue was then excised in small chunks and washed in ice cold phos- 
phate buffered saline (PBS) to remove excess blood. The villous tissue 
was then resuspended in 5 volumes of ice cold PBS and gently stirred 
for 30 min. The suspension was then centrifuged at 300 x g for 15 min 
and the supernatant decanted through a 250 brn pore size nylon mesh. 
The supernatant was then used as the source of the microvillous mem- 
brane fraction whereas the sedimented tissue was further treated to 
isolate basal membrane fraction as described [14]. 
Both the microvillous and basal membrane preparations were sus- 
pended in 50 mM Tris-HCl, pH 7.4, 250 mM sucrose, 1 mM EDTA, 
1 mM PMSF and 0.02% sodium azide. The membranes were stored at 
-80°C for further use. Protein was determined by the Bradford method 
using bovine serum albumin as a standard [15]. 
2.3. Alkaline phosphatase assay 
Alkaline phosphatase activity of the purified membranes was deter- 
mined by the release ofp-nitrophenol fromp-nitrophenol phosphate in 
a carbonate/bicarbonate buffer, pH 10.5 at 37°C as described [16]. 
2.4. [-‘HI Dihydroalprenol binding assay 
Binding of [‘Hldihydroalprenol to the purified membrane frac- 
tions was carried out as described before [17]. Membrane suspensions 
(125 pug protein) were incubated in 150 ~1 incubation medium contain- 
ing 50 mM Tris-HCl, 10 mM MgC&, pH 7.4 for 15 min at 37°C with 
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1 x IO-’ M [‘H]dihydroalprenol. Incubations were terminated by dilut- 
ing a 150 ~1 incubation mixture with 2 ml of ice-cold incubation me- 
dium, followed by rapid vacuum filtration of the suspension using 
Whatman glass fibre filter paper GF/C. Filters were dried and radioac- 
tivity bound to the filter paper was determined in a scintillation counter. 
In parallel, non-specific binding was determined by incubating the radio 
ligand in the presence of excess oL-propanolol. 
2.5. Fatty acid binding studies 
Binding of [“‘Cloleate or [‘4C]linoleate to the purified microvillous 
and basal membranes was determined as described previously [12,13]. 
Non-specific binding of each radiolabelled fatty acid was determined 
by adding a 20-fold excess of the corresponding unlabelled fatty acid 
to the assay tube, and specific binding was calculated by subtracting the 
non-specific binding from the total binding (in the absence of excess 
unlabelled fatty acid). 
2.6 Polyacrylamide gel electrophoresis radiobinding assay of FABP,, 
Polyacrylamide gel electrophoresis (PAGE) radiobinding assay was 
used as previously described for the detection of FABP,, in solubilized 
membrane proteins from both human and sheep placenta [12,13]. 
Briefly, both microvillous and basal membranes were solubilised with 
Triton X-100, and the solubilised membranes were then incubated over- 
night at 4°C with a tracer amount of [“‘Cloleate in the absence or in 
the presence of excess unlabelled oleic acid. The incubation mixture was 
then subjected to non-denaturing PAGE with 20% acrylamide. At the 
end of the electrophoresis, the gel was transferred onto a nitro-cellulose 
sheet, dried and autoradiographed with Hyper film-p Max (Amersham 
International, UK). The film took around 3 to 5 days for development. 
Bands were visible on the film depending on the [‘4C]oleate binding 
activity of the protein. 
2.7. Electrophoretic separation of membrane proteins and Western blot 
unulysis of membrane proteins 
Polyclonal antisera against the purified human placental FABP,, 
was used [12]. Western blot analysis of membrane proteins from mi- 
crovillous and basal membranes was carried out as described before 
[12]. Polyacrylamide gel electrophoresis of these membrane vesicles in 
the presence of sodium dodecyl sulphate (SDS) was carried out under 
reducing conditions on SDS-PAGE gel homogeneous 20 (Phast System, 
Pharmacia, UK), as described [12]. After electrophoresis, proteins were 
transferred onto a nitro-cellulose membrane by diffusion blotting at 
70°C for 1 h. The membrane was probed for the presence of FABP,, 
by incubating with rabbit polyclonal antiserum to human placental 
FABP,,,. Antibody antigen complexes were then detected with HRP- 
anti-rabbit IgG fraction of donkey polyclonal antiserum (Scottish An- 
tibody Production Unit). 
3. Results 
3. I. PuriJication of placental membranes 
Table 1 shows the distribution of the alkaline phosphatase 
activity, and dihydroalprenolol binding activity in the purified 
microvillous and basal membrane fractions obtained from the 
full term human placentas. The microvillous membranes were 
enriched around 20-fold in alkaline phosphatase activity, the 
marker for the microvillous membranes, whereas the basal 
membranes was enriched around 3%fold in dihydroalprenolol 
binding, the marker for basal membranes. This indicates that 
the membrane preparations were free of cross-contamination. 
3.2. Binding of r~diolabe~led~atty acids to membranes 
Binding of [‘4C]oIeate or [‘4C]linoleate to placental mem- 
branes attained equilibrium within 20 min of incubation at 
37°C at I : 1 molar ratio of fatty acid and albumin. Specific 
binding for [‘4C]linoleate and [‘4C]oleate to the purified micro- 
villous membranes was 1.92 ? 0.19 nmol/mg of protein (n = 3) 
and 1.55 f 0.03 nmoYmg of protein (n = 3), respectively. 
Whereas the specific binding for these fatty acids to the purified 
Fig. 1. Autoradiography of FABP,, of solubilised microvillous and 
basal membranes. Autoblot of 20% homogeneous native PAGE gel. 
Lanes 1 and 2: Solubilsed proteins from the microvillous membranes; 
Lanes 3 and 4: Solubilised proteins from basal membranes, Approxi- 
mately, 15 pug membrane proteins were used. All samples were incu- 
bated with [‘4C]oleate whereas the samples in lanes 2 and 4 were incu- 
bated in the presence of excess unlabelled oleic acid. 
basal membranes was insignificant; [‘4C]oleate binding 
(0.13 f 0.02 nmol/mg of protein), [‘4C]linoleate binding 
(0.05 + 0.02 nmol/mg of protein). Binding of [‘4C]linoleate to 
microvillous membranes was around 38-fold higher compared 
with that of the basal membranes (P < O.OOl), whereas 
[‘4C]oleate binding to the microvillous membranes was around 
12-fold higher (P < 0.001). 
3.3. Polyacrylamide gel electrophoresis radiobinding assay 
Fig. 1 shows the [14C]fatty acid binding activity of the solubil- 
ised proteins from the purified microvillous and basal mem- 
branes in an auto blot. Solubilised proteins from these mem- 
branes were incubated with radiolabelled oleate and subse- 
quently examined by autoradiography, only one radioactive 
band was visible in the solubilised proteins from microvillous 
membranes which was abolished in the presence of excess oleic 
acid. Whereas no radioactive band was visible in the case of 
solubilised proteins from basal membranes. The radioactive 
band corresponded to that of the purified human placental 
FABP,, (data not shown). 
3.4. Detection of FABP,, in the membrane j?actions by 
Western blot analysis 
The presence of the FABP,, in the microvillous and basal 
membrane fractions, was examined by Western blot analysis 
using anti-FABP,, polyclonal antiserum. Fig. 2 shows a single 
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band in the microvillous membranes but not in the basal mem- 
branes. This provides further evidence for the presence of the 
1 ‘ABP,, in the microvillous membranes. 
4. Discussion 
The studies presented in the paper attempt to determine the 
1 Ication of FABP,, in the purified syncytiotrophoblast mem- 
1 ranes: microvillous and basal membranes. The mechanism by 
1 which the placenta takes up fatty acid from the maternal circu- 
1 rtion and subsequently transports them to the fetus is still not 
~ Jell understood. Recently, we identified and characterised a 
/ ‘ABP,, in human placental membranes, and suggested that 
’ his protein may be responsible for fatty acid uptake from the 
: maternal circulation [5,12]. The syncytiotrophoblast of the pla- 
L enta is the site of exchange of nutrients and minerals between 
he mother and fetus [18]. Therefore, it is of paramount impor- 
ante to characterize the transport of fatty acids using purified 
lipolar syncytiotrophoblast membranes. Studies have shown 
symmetrical distribution of various receptors and enzymes in 
he membranes of this cell [ 14,17,18]. Asymmetric distribution 
If the transporting proteins may allow the accumulation of 
mportant molecules in the syncytiotrophoblast and their sub- 
equent extrusion to the fetal circulation. In our previous stud- 
:s, the membranes were prepared from placental syncytiotro- 
Jhoblasts which might have both the bipolar membranes; mi- 
rovillous (maternal facing side) and the basal membranes 
7. ‘lg. 2. Representative Western blot of the microvillous and the basal 
lnembranes showing immunoreactivity with mono specific anti- 
!;ABP,, antisera. Western blots of the proteins from the microvillous 
.tnd basal membranes were carried out as described in section 2. Lane 
, Microvillous membrane proteins; Lane 2, Basal membrane proteins. 
ipproximately 15 fig membrane proteins were used. 
Table 1 
Parameters of membrane purity in microvillous membranes and basal 
membranes of human placenta 
Markers Microvillous Basal membranes 
membranes 
Alkaline phosphatase @g 
phenol/min/mg protein) 
2216 f 159 347 C 67 
[3H]dihydroalprenololbinding 
activity (pmol/mg protein) 
0.06 + 0.004 4.4 ?r 0.69 
Values are expressed as the mean + S.E.M. of three different experi- 
ments. 
(fetal facing side) [12]. Now, using a different method [14] the 
sequential production of highly purified microvillous and basal 
membranes in significant quantities from placentas was possi- 
ble and allowed us to perform comparative studies using either 
side of syncytiotrophoblast membranes from the same pla- 
centa. 
Direct comparison of the binding of radiolabelled fatty acids 
to these membranes indicate that the maximal binding was in 
the microvillous membranes compared with that in the basal 
membranes. Our fatty acid binding data on the purified mem- 
branes were similar to those reported earlier by Lafond et al. 
[ 191. This was further confirmed by using PAGE/autoradioblot- 
ting of these membranes. We showed earlier that the PAGE/ 
autoradioblotting technique could be used to identify 
FABP,, in solubilised membranes [ 12,131. Auto blot 
of the membrane proteins clearly shows the presence of a 
FABP,, in the microvillous membranes but not in the basal 
membrane fractions. Similarly, monospecifc antiserum against 
the FABP,,, which was used previously to identify the 
FABP,,in the placental membranes and was found to 
inhibit significantly the binding of [14C]fatty acids to the mem- 
branes [12], produced a single band with solubilised proteins 
from the microvillous membranes but not with the basal mem- 
branes. All the above data clearly demonstrate that the microv- 
illous membranes bind significant amounts of FFA and that the 
FABP,, is located exclusively in these membranes. Thus, it may 
represent a unidirectional transport of FFA from the mother 
to fetus. 
The physiological significance of our observation is appar- 
ent. Like LPL. FABP,, is also located in the maternal facing 
membranes of the placenta. Both the membrane proteins are 
thought to be involved in the sequestration of FFA by the 
placenta and therefore they may play a critical role in fetal 
growth and development [4,5]. Increasing knowledge of the 
fatty acid transporter protein in the placenta, and other envi- 
ronmental modifiers of this protein is required to understand 
feto-placental fatty acid metabolism. 
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